Skip to content

Randomised trial, 2024

Does sertraline change brain chemicals in people with PMDD, and does this relate to symptom improvement?

Sertraline changed specific brain chemical levels (pregnanolone) in people with PMDD compared to baseline. However, whether these chemical changes directly caused symptom improvement was not tested.

Moderate study design 32 women with PMDD and 38 healthy women

What they did

A study measuring nine different neuroactive steroid levels (brain chemicals) in 38 healthy women and 32 women with PMDD during different phases of their cycle. In the PMDD group, these chemicals were measured again during a cycle when they took 50 mg sertraline from ovulation to menstruation.

What they found

There were no baseline differences in neuroactive steroid levels between healthy women and those with PMDD. During sertraline treatment, the PMDD group showed a significant increase in pregnanolone levels and the pregnanolone:progesterone ratio, and a decrease in 3 alpha 5 alpha-androsterone. The study did not directly test whether these chemical changes linked to symptom improvement.

What it means for you

Sertraline may work in PMDD by changing specific brain chemical levels, but this study did not confirm that these chemical changes directly cause symptom improvement. The main limit is that this was not a placebo-controlled study, so we cannot be sure the changes were due to the medication.

32

women with PMDD

38

healthy controls

50

mg sertraline daily

About the study

Original title
GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder
Authors
Miller KN, Standeven L, Morrow AL et al.
Journal
Psychoneuroendocrinology
Year
2024
Study design
Randomised trial
Participants
32
What was tested
50 mg sertraline daily from ovulation to menstruation
Open access
Yes

Topics